Guardian Pharmacy Services GRDN
$46.94 +$0.27 (+0.58%)
Market closed · Nov 22, 6:40 am ET · Last extended-hours $46.94 0.00%
Open$46.40
Prev close$46.67
Day range$46.13 – $47.48
Volume526.7K
Market cap$2.97B
P/E (TTM)40.1
Dividend yield–
GRDN Stock News
Headlines matching Guardian Pharmacy Services or the GRDN ticker, most recent first.
- KeyBanc Initiates Guardian Pharmacy Services(GRDN.US) With Buy Rating, Announces Target Price $52
- Truist Financial Maintains Guardian Pharmacy Services(GRDN.US) With Buy Rating, Announces Target Price $51
- BofA Securities Maintains Guardian Pharmacy Services(GRDN.US) With Buy Rating, Maintains Target Price $47
- Analysts Conflicted on These NA Names: Starz Entertainment Corp (STRZ), Guardian Pharmacy Services, Inc. Class A (GRDN) and MSC Income Fund, Inc. (MSIF)
- Analysts Offer Insights on NA Companies: Emerson Electric Company (EMR), Omada Health, Inc. (OMDA) and Guardian Pharmacy Services, Inc. Class A (GRDN)
- Oppenheimer Maintains Guardian Pharmacy Services(GRDN.US) With Buy Rating, Raises Target Price to $49 Positive
- Earnings Flash (GRDN) Guardian Pharmacy Services, Inc. Reports Q2 Revenue $351.8M, Vs. FactSet Est of $340.4M
- Stephens Remains a Buy on Guardian Pharmacy Services, Inc. Class A (GRDN)
- Oppenheimer Sticks to Its Buy Rating for Guardian Pharmacy Services, Inc. Class A (GRDN)
- Truist Financial Maintains Guardian Pharmacy Services(GRDN.US) With Buy Rating
- BofA Securities Maintains Guardian Pharmacy Services(GRDN.US) With Buy Rating, Announces Target Price $47
- BofA Securities Maintains Guardian Pharmacy Services(GRDN.US) With Buy Rating
- Analysts Are Bullish on These Healthcare Stocks: Amylyx Pharmaceuticals Inc (AMLX), Guardian Pharmacy Services, Inc. Class A (GRDN) Positive
- Stephens Keeps Their Buy Rating on Guardian Pharmacy Services, Inc. Class A (GRDN)
- Truist Financial Sticks to Their Buy Rating for Guardian Pharmacy Services, Inc. Class A (GRDN)
No comments yet — be the first to weigh in on GRDN.
Sign in to join the discussion.